FDP
VRTX icon

Financiere des Professionnels’s Vertex Pharmaceuticals VRTX Stock Holding History

Financiere des Professionnels’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
4,685
+4,060
+650% +$1.89M 0.12% 147
2025
Q4 		$283K Buy
+625
New +$269K 0.02% 260

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financiere des Professionnels's VRTX Position: Q1 2026 in Review

Financiere des Professionnels increased its Vertex Pharmaceuticals (VRTX) stake by 650% in Q1 2026, buying an estimated $1.89M and bringing the position to 4,685 shares worth $2.09M. The position accounts for 0.12% of the portfolio, ranked #147.

Financiere des Professionnels first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Financiere des Professionnels held 4,685 shares of Vertex Pharmaceuticals worth $2.09M as of Q1 2026.
  • Financiere des Professionnels bought 4,060 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.89M.
  • Vertex Pharmaceuticals made up 0.12% of Financiere des Professionnels's portfolio in Q1 2026, its #147 holding.
  • Financiere des Professionnels first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.